Alladapt Immunotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Alladapt Immunotherapeutics's estimated annual revenue is currently $2.6M per year.
- Alladapt Immunotherapeutics's estimated revenue per employee is $77,500
Employee Data
- Alladapt Immunotherapeutics has 34 Employees.
- Alladapt Immunotherapeutics grew their employee count by -37% last year.
Alladapt Immunotherapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO and Co-Founder | Reveal Email/Phone |
2 | SVP Manufacturing and CMC | Reveal Email/Phone |
3 | SVP Supply Chain and Operations | Reveal Email/Phone |
4 | SVP, Development Operations | Reveal Email/Phone |
5 | VP, Information Technology & Business Operations | Reveal Email/Phone |
6 | Director, Manufacturing and CMC | Reveal Email/Phone |
7 | Sr. Director QC and Analytical Development | Reveal Email/Phone |
8 | Director, Analytical Development | Reveal Email/Phone |
9 | Chief Technical Officer | Reveal Email/Phone |
10 | Associate Director FP&A | Reveal Email/Phone |
Alladapt Immunotherapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Alladapt Immunotherapeutics?
A biopharmaceutical company developing prescription therapies for unmet needs in the field of Food Allergy
keywords:N/AN/A
Total Funding
34
Number of Employees
$2.6M
Revenue (est)
-37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.3M | 34 | -61% | N/A |
#2 | $4.9M | 34 | 10% | N/A |
#3 | $7.9M | 34 | 10% | N/A |
#4 | $3M | 34 | -43% | N/A |
#5 | $4.1M | 35 | 9% | N/A |